Workflow
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
Globenewswire· 2025-11-24 13:00
Core Insights - Ceribell, Inc. has received FDA 510(k) clearance for its Clarity algorithm, making it the first and only AI-powered EEG technology for detecting electrographic seizures in patients from pre-term neonates to adults [1][3] Group 1: Product and Technology - The Ceribell System combines proprietary algorithms with specialized hardware to enable real-time detection of non-convulsive seizures in neonatal patients, facilitating rapid diagnosis and treatment [3] - The FDA clearance was supported by EEG data from over 700 patients, representing the largest validation dataset for a neonatal seizure detection system [3] Group 2: Market Need and Impact - Early detection of seizures is critical in neonatal care, with approximately 9% of NICU patients diagnosed with seizures, while up to 90% may go undetected without EEG monitoring [2] - High-risk newborns who experience prolonged seizures have an 8-fold increased risk of poor outcomes, including mortality and long-term disability [2] - Recent guidelines recommend continuous EEG monitoring for neonates at high risk for seizures, highlighting the need for timely intervention [2] Group 3: Company Vision and Leadership - The CEO of Ceribell emphasized the importance of timely and accessible seizure detection for newborns, aiming to reduce delays and improve outcomes [4] - The Medical Director of Neonatal ECMO at Stanford Children's Hospital noted the lack of 24/7 EEG access in many NICUs, underscoring the need for faster, more accessible tools for evaluating brain activity [4] Group 4: Company Overview - Ceribell is focused on transforming the diagnosis and management of serious neurological conditions, with its system currently utilized in intensive care units and emergency rooms across the U.S. [7] - The company is headquartered in Sunnyvale, California, and aims to address unmet needs in acute care settings through its innovative EEG platform [7]
GigaCloud Technology Inc to Participate in UBS Global Technology and AI Conference
Globenewswire· 2025-11-24 13:00
EL MONTE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Larry Wu, it’s Founder and Chief Executive Officer, and Erica Wei, its Chief Financial Officer, will conduct one-on-one meetings with investors at the 2025 UBS Global Technology and AI Conference, being held from December 1 through December 4 in Scottsdale, Arizona. To schedule a m ...
Everything Blockchain Launches AI Event Trading Desk for Polymarket Prediction Markets
Globenewswire· 2025-11-24 13:00
The company’s AI Event Trading Desk prices and trades Polymarket prediction markets with EBZT capital in search of scalable, hedged trading profitsJacksonville, FL, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Everything Blockchain Inc. (OTC: EBZT), a public AI development lab for digital asset markets, today announced the launch of an AI Event Trading Desk that uses company capital to price and trade prediction markets on Polymarket. The desk is built to turn mispriced odds on real world events, including elections, ...
American Hotel Income Properties REIT LP Announces Completion of Its Normal Course Issuer Bid
Globenewswire· 2025-11-24 13:00
Core Viewpoint - American Hotel Income Properties REIT LP (AHIP) has completed its normal course issuer bid (NCIB) and automatic securities purchase plan (ASPP), purchasing approximately 10% of its public float [1][2]. Group 1: NCIB and ASPP Details - AHIP purchased a total of 7,521,189 units under the NCIB and ASPP at a weighted average price of Cdn$0.43 per unit [2]. - The total outstanding units of AHIP currently stand at 71,890,348 [2]. - AHIP plans to apply for the renewal of its NCIB and ASPP for an additional twelve months, from December 30, 2025, to December 29, 2026, pending approval from the Toronto Stock Exchange [2]. Group 2: Company Overview - AHIP is a limited partnership focused on investing in hotel real estate properties across the United States, primarily in premium branded, select-service hotels located in secondary metropolitan markets [3]. - The hotels operate under brands affiliated with Marriott, Hilton, and IHG Hotels through license agreements [3]. - The long-term objectives of AHIP include increasing the value of its hotel properties through operational excellence, active asset management, and capital expenditures, as well as enhancing unitholder value and distributions [3].
Xcel Brands Partners with At Home with Shannon to Launch a New Era of Inspired Living Through Longaberger
Globenewswire· 2025-11-24 13:00
Core Insights - Xcel Brands, Inc. announces a partnership between Longaberger and Shannon Doherty to launch a new home collection that emphasizes warmth, style, and functionality [2][3] Company Overview - Xcel Brands, Inc. is a media and consumer products company focused on influencer-driven brands through social commerce and livestreaming, with a portfolio that includes Halston, Judith Ripka, and Longaberger [6] - The company has generated over $5 billion in retail sales via livestreaming and interactive television, reaching over 43 million social media followers and broadcasting into 200 million households [6] Partnership Details - The collaboration between Longaberger and Shannon Doherty aims to blend American craftsmanship with a family-centered lifestyle, celebrating everyday living and creating a modern vision for the home [3][5] - Each product in the new collection will reflect Longaberger's handcrafted quality combined with Shannon's warmth and approachability, focusing on cozy entertaining and functional storage [5] Brand Background - Longaberger, founded in 1973, is known for its artisanal handcrafted products, particularly handmade maple baskets, and has a loyal customer base [7] - Shannon Doherty, founder of At Home with Shannon, shares home décor ideas and family routines, reaching millions through her lifestyle platform [8]
Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
Globenewswire· 2025-11-24 13:00
Core Insights - Soleno Therapeutics, Inc. is participating in the Piper Sandler 37 Healthcare Conference on December 4, 2025, with CEO Anish Bhatnagar scheduled for a fireside chat [1] Company Overview - Soleno Therapeutics focuses on developing and commercializing novel therapeutics for rare diseases [3] - The company's first commercial product is VYKAT™ XR (diazoxide choline) extended-release tablets, designed for treating hyperphagia in individuals with Prader-Willi syndrome aged 4 years and older [3]
Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations
Globenewswire· 2025-11-24 13:00
Core Insights - Cidara Therapeutics has completed target enrollment of 6,000 participants in its Phase 3 ANCHOR trial for CD388, a non-vaccine preventative for seasonal influenza, aimed at high-risk populations [1][2] - The trial will conduct an interim analysis in Q1 2026 to evaluate the need for additional enrollment during the Southern Hemisphere flu season [1][2] - CD388 is designed to be administered as a single 450-milligram subcutaneous dose and aims for potential BLA approval if the trial results are successful [2][4] Company Overview - Cidara Therapeutics utilizes its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) therapeutics, with CD388 being its lead candidate for influenza prevention [4] - The company is headquartered in San Diego, California, and has received Fast Track Designation from the FDA for CD388 [4] - Positive results from the Phase 2b NAVIGATE trial were announced in June 2025, leading to the initiation of the Phase 3 ANCHOR trial in September 2025 [4]
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
Globenewswire· 2025-11-24 13:00
Grant funding will support continued progress on a preclinical research program to identify and develop a non-hormonal intravaginal contraceptive innovation aimed at addressing unmet global needsSAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that it has received an approximately $3.6 million payment under an exist ...
Hollister and Taco Bell Turn Y2K Nostalgia into the Season's Spiciest Drop
Globenewswire· 2025-11-24 13:00
Core Insights - Hollister Co. and Taco Bell are launching a limited-edition collaboration on December 1, 2025, featuring a Y2K-inspired capsule collection that combines Hollister's Feel Good Fleece with Taco Bell's branding [1][3][4] Product Details - The collection includes 11 apparel styles, such as retro-style hoodies, joggers, graphic tees, baggy denim, and cozy socks, all designed to reflect a nostalgic Y2K aesthetic [1][2][6] - Prices for the apparel range from $14.95 to $79.95, with sizes available from XS to XL [4] Marketing Strategy - The collaboration aims to resonate with youth culture, leveraging nostalgia while appealing to a new generation [3][4] - Taco Bell Rewards Members will have early access to the collection and a chance to win limited-edition sweatshirts through an in-app promotion [5][10]
Launch of the Chessnut Evo: The Electronic Chessboard of the Future
Globenewswire· 2025-11-24 13:00
Core Insights - Chessnut is launching its flagship model, the Chessnut Evo, in Europe, which integrates elegant design, built-in AI, and an immersive playing experience [1][11]. Product Features - The Chessnut Evo targets chess enthusiasts who desire a blend of traditional aesthetics and digital functionality, featuring a 12.3-inch touchscreen display (1920×720) that provides real-time move displays, analyses, and visual aids [4]. - The board utilizes full piece recognition for instant setup, allowing players to start games immediately by placing pieces on the board [4]. - It is powered by an octa-core processor and a dedicated NPU for AI, offering a more natural learning experience through its MAIA-style AI, which mimics human gameplay strategies [6]. Training and Learning Capabilities - The Chessnut Evo allows users to train against a personalized engine based on their favorite chess masters, enhancing their gameplay through engagement with expert strategies [8]. - Players can also train against familiar opponents, improving their ability to counter specific moves and develop effective strategies [9]. - The board provides opportunities to learn from past losses by identifying weaknesses and offering tailored exercises for improvement [9]. Connectivity and Software - The Chessnut Evo supports online play via platforms like Lichess and Chess.com, directly through its Android 11 interface or the Chessnut Bridge app [10]. - Its software ecosystem is designed to evolve continuously, providing firmware updates and new analysis features to ensure longevity and relevance in the market [10]. Market Positioning - According to industry expert Mickaël Cailleau, the Chessnut Evo represents a new generation of electronic chessboards, functioning as a personal coach that combines AI, visual comfort, and complete connectivity, making it the most advanced solution for training and online play without needing an external screen [11].